Baseball Legend John Smoltz Featured on PLx Pharma’s Social Channels
September 12 2022 - 4:30PM
PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a
commercial-stage drug delivery platform technology company focused
on its clinically-validated and patent-protected PLxGuard™ that has
the potential to improve the absorption of many drugs currently on
the market and to reduce the risk of stomach injury associated with
certain drugs. The Company, with its lead products VAZALORE 81 mg
and VAZALORE 325 mg liquid-filled aspirin capsules (referred
together as “VAZALORE®”), has launched a new VAZALORE 325 mg
advertising campaign on Facebook featuring legendary professional
baseball pitcher and avid golfer John Smoltz.
“From baseball to golf, I don’t want aches and
pains to slow me down,” said Smoltz. “VAZALORE is the only pain
reliever I have found that works quickly on my aches and pains and
doesn’t upset my stomach.”
“September is Pain Awareness Month, a time
dedicated to raising awareness of pain and pain management options,
like aspirin. We are very excited to launch our new Facebook
campaign with John, a current VAZALORE user and believer in its
many benefits,” said Natasha Giordano, President & CEO of PLx
Pharma. “Millions of people rely on aspirin for the temporary
relief of minor aches and pains. The unique complex inside VAZALORE
capsules allows for targeted release of aspirin to temporarily
relieve minor aches and pains and is specially designed to help
protect the stomach.”
PLx Pharma’s VAZALORE is the first and only U.S.
Food and Drug Administration (FDA)-approved liquid-filled aspirin
capsule. The product was launched in August 2021 and is available
over the counter in more than 30,000 drugstores, supermarkets, mass
merchandisers and e-commerce sites nationwide.
About VAZALORE
VAZALORE is an FDA-approved liquid-filled
aspirin capsule, available in 81 mg and 325 mg doses. VAZALORE
delivers aspirin differently from plain and enteric coated aspirin
products. The special complex inside the capsule is designed for
targeted release of aspirin, limiting its direct contact with the
stomach. VAZALORE delivers fast, reliable absorption for pain
relief plus the lifesaving benefits of aspirin. To learn more about
VAZALORE®, please visit www.vazalore.com and follow us on
Facebook.
About PLx Pharma Inc.
PLx Pharma Inc. is a commercial-stage drug
delivery platform technology company focused on improving how and
where active pharmaceutical ingredients (APIs) are absorbed in the
gastrointestinal (GI) tract via its clinically validated and patent
protected PLxGuard™ technology. PLx believes this platform has the
potential to improve the absorption of many drugs currently on the
market or in development, and to reduce the risk of stomach injury
associated with certain drugs. To learn more about PLx Pharma Inc.
and its pipeline, please visit www.plxpharma.com and follow us on
LinkedIn and Twitter.
CONTACTS:
Janet M. BarthVice President, Investor Relations & Corporate
Communications, PLx Pharma Inc.(973) 409-6542IR@PLxPharma.com
Lisa M. WilsonFounder & President, In-Site Communications,
Inc.(212) 452-2793lwilson@insitecony.com
Source: PLx Pharma Inc.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/c1a8bf56-ba0f-47b5-8710-08458436b0e4
PLx Pharma (NASDAQ:PLXP)
Historical Stock Chart
From Sep 2024 to Oct 2024
PLx Pharma (NASDAQ:PLXP)
Historical Stock Chart
From Oct 2023 to Oct 2024